---
title: "Modular Event-Based Architecture for Dynamic Evaluation of the Sepsis Pathway Using eMR Data"
id: "medrxiv-6-a-modular-architecture-for-dynamic-evaluation-of-best-practice-care"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-6-a-modular-architecture-for-dynamic-evaluation-of-best-practice-care"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1?rss=1"
published_at: "2026-10-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Modular Event-Based Architecture for Dynamic Evaluation of the Sepsis Pathway Using eMR Data
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-6-a-modular-architecture-for-dynamic-evaluation-of-best-practice-care
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1?rss=1)
- **Published At:** 2026-10-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study presents a **modular event-based architecture** to evaluate adherence to the New South Wales Adult **Sepsis Pathway** using routine electronic medical record (**eMR**) data from emergency department encounters. - Data were collected from four hospitals between July 2022 and June 2024 and processed through three sequential layers: event-stream transformation, pathway-relevance filtering, and state-based pathway evaluation. - Heterogeneous clinical records were standardized and organized into chronological encounter-level timelines so pathway state could be updated as new information arrived. - The pipeline processed 451,124 encounters and extracted 57,631,084 clinical events; after pathway relevance filtering, 43,951,146 events remained (76.3%). - Of processed encounters, 129,907 (34.6%) entered the sepsis pathway; 50,118 (38.6% of those) entered YELLOW state (suspected sepsis) and 3,349 (2.6% from GREEN) progressed to RED state (initial shock). - Among the 50,118 encounters entering YELLOW, 2,426 (4.8%) progressed to shock, 8,700 (17.4%) were recognized via a blood culture order, and 4,287 (8.6%) were recognized via an antibiotic order. - The architecture prioritized higher-acuity states during evaluation, allowing recognition of sepsis via discrete events (blood culture or antibiotic orders) without requiring intermediate states. - Separating data preparation from pathway rules improved transparency, maintainability, and adaptability and supports a reusable longitudinal representation for context-dependent pathway evaluation and future near-real-time monitoring. - Ethical approval was obtained from the Western Sydney Local Health District Human Research Ethics Committee (2019/ETH09607). Data are available on reasonable request to the authors.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=zxOzF3cylAOA_Cb6vmU7OiarGRAN0X6TzWhRIlHK7sk-1791331415.6026173-1.2.1.1-8O.qd3W11BD.w2xyCLwFnLOQO1npIDcNh0FLAAHyNBgqSNwc4q9wAo.m5cwG7xk1) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # A Modular Architecture for Dynamic Evaluation of Best-Practice Care [ View ORCID Profile](http://orcid.org/0009-0007-4626-2953)Minh Trang Hoang, [ View ORCID Profile](http://orcid.org/0000-0003-0783-1918)Tim Shaw, [ View ORCID Profile](http://orcid.org/0009-0000-0136-8147)Christina Igasto, [ View ORCID Profile](http://orcid.org/0000-0003-4398-2908)Candice Donnelly, [ View ORCID Profile](http://orcid.org/0000-0001-7349-1128)Amith Shetty, [ View ORCID Profile](http://orcid.org/0009-0003-3295-1046)Malcolm Pradhan doi: https://doi.org/10.64898/2026.10.03.26364324 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Minh Trang Hoang 1 Faculty of Medicine and Health, The Univeristy of Sydney; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Minh%2BTrang%2BHoang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hoang%20MT&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMinh%2BTrang%2BHoang%2B) * [ORCID record for Minh Trang Hoang](http://orcid.org/0009-0007-4626-2953 "Open in new tab") * For correspondence: jane.hoang@sydney.edu.au Tim Shaw 1 Faculty of Medicine and Health, The Univeristy of Sydney; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tim%2BShaw%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shaw%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATim%2BShaw%2B) * [ORCID record for Tim Shaw](http://orcid.org/0000-0003-0783-1918 "Open in new tab") Christina Igasto 2 Digital Canberra; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christina%2BIgasto%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Igasto%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristina%2BIgasto%2B) * [ORCID record for Christina Igasto](http://orcid.org/0009-0000-0136-8147 "Open in new tab") Candice Donnelly 1 Faculty of Medicine and Health, The Univeristy of Sydney; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Candice%2BDonnelly%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Donnelly%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACandice%2BDonnelly%2B) * [ORCID record for Candice Donnelly](http://orcid.org/0000-0003-4398-2908 "Open in new tab") Amith Shetty 3 NSW Ministry of Heatlh * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Amith%2BShetty%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shetty%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAmith%2BShetty%2B) * [ORCID record for Amith Shetty](http://orcid.org/0000-0001-7349-1128 "Open in new tab") Malcolm Pradhan 1 Faculty of Medicine and Health, The Univeristy of Sydney; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Malcolm%2BPradhan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pradhan%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMalcolm%2BPradhan%2B) * [ORCID record for Malcolm Pradhan](http://orcid.org/0009-0003-3295-1046 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1315216/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1315216/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1315216/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1315216/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1315216/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objective: Retrospective evaluation of clinical pathway adherence using electronic medical record (eMR) data is limited by heterogeneous data structures and statistical measures that do not account for patient-specific context, care sequence, or timing. We designed a modular event-based architecture to dynamically evaluate the New South Wales Adult Sepsis Pathway over time. Method: Data from eMRs were collected from adult emergency department encounters across four hospitals between July 2022 and June 2024 and processed through three sequential layers: event-stream transformation, pathway-relevance filtering, and state-based pathway evaluation. Heterogeneous records were standardized and organized into a chronological timeline for each encounter. The framework then updated the pathway state as new clinical information became available and assessed whether recommended care was delivered within the relevant timeframe and sequence. Result: The architecture processed 451,124 encounters. This included 57,631,084 clinical events extracted and transformed into encounter-level event streams. After filtering for pathway relevance, 43,951,146 events remained (76.3%). A total of 129,907 (34.6%) encounters entered the sepsis pathway, 50,118 (38.6%) entered YELLOW state, indicating progression to suspected sepsis, and 3,349 (2.6%) encounters progressed to RED state from GREEN, indicating the initial shock. Of 50,118 encounters entering YELLOW state, 2,426 (4.8%) progressed to shock, 8,700 (17.4%) encounters were recognized with sepsis through a blood culture order, and 4,287 (8.6%) encounters were recognized with sepsis through an antibiotic order. This demonstrates the ability of the architecture to prioritize higher-acuity states during evaluation rather than going through an intermediate state. Conclusion: The architecture developed shows the feasibility of transforming fragmented routine eMR data into a reusable longitudinal representation that supports context-dependent pathway evaluation. Separating data preparation from pathway rules improves transparency, maintainability, and adaptability and provides a foundation for future interoperable, near-real-time pathway monitoring ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by the Western Sydney Local Health District Human Research Ethics Committee (2019/ETH09607). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared Digital Health Cooperative Research Centre, https://ror.org/02n8xct56 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.10.03.26364646v1 "Phantom Fairness: A Reproducible Audit of How Automatically Extracted Labels Can Conceal Demographic Disparities in Chest Radiograph Classifiers")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.02.26364350v1 "Leveraging Skin Mutagenesis to Uncover Genetic Cancer Susceptibilities") Posted October 06, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/06/2026.10.03.26364324.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.03.26364324v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/06/2026.10.03.26364324.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) A Modular Architecture for Dynamic Evaluation of Best-Practice Care Minh Trang Hoang, Tim Shaw, Christina Igasto, Candice Donnelly, Amith Shetty, Malcolm Pradhan medRxiv 2026.10.03.26364324; doi: https://doi.org/10.64898/2026.10.03.26364324 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.03.26364324v1%26text%3DA%2520Modular%2520Architecture%2520for%2520Dynamic%2520Evaluation%2520of%2520Best-Practice%2520Care "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.03.26364324v1%26t%3DA%2520Modular%2520Architecture%2520for%2520Dynamic%2520Evaluation%2520of%2520Best-Practice%2520Care "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.03.26364324v1%26title%3DA%2520Modular%2520Architecture%2520for%2520Dynamic%2520Evaluation%2520of%2520Best-Practice%2520Care%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.03.26364324v1%26title%3DA%2520Modular%2520Architecture%2520for%2520Dynamic%2520Evaluation%2520of%2520Best-Practice%2520Care "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.03.26364324) ## Subject Area * [Health Informatics ](https://www.medrxiv.org/collection/health-informatics) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (626) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (341) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4887) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (486) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (421) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (660) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1647) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16070) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (34) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1218) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7129) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (737) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1073) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5130) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1447) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1794) * [Hematology](https://www.medrxiv.org/collection/hematology) (591) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1356) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16363) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1185) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (678) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (729) * [Neurology](https://www.medrxiv.org/collection/neurology) (7391) * [Nursing](https://www.medrxiv.org/collection/nursing) (371) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1102) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1263) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1010) * [Oncology](https://www.medrxiv.org/collection/oncology) (3662) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1068) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (399) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (460) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (484) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (142) * [Pathology](https://www.medrxiv.org/collection/pathology) (712) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1823) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (741) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (777) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5993) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9842) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2467) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1480) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1257) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (653) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (786) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (588) * [Surgery](https://www.medrxiv.org/collection/surgery) (786) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (310) * [Urology](https://www.medrxiv.org/collection/urology) (299) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP me
## Related Clinical Research

- [Predictors of Mortality and HIE Severity in Neonates at Jimma University Medical Center](https://medichelpline.com/clinical-feed/pubmed-42860536.md) (DOI: 10.1186/s40748-026-00309-z)
- [Predicting In-Hospital Mortality at 72 Hours in ICU Patients with Sepsis and Hypertension](https://medichelpline.com/clinical-feed/medrxiv-0-prediction-of-in-hospital-mortality-at-a-72-hour-intensive-care-landmark-in.md)
- [Imeglimin pretreatment reduces sepsis-associated AKI and improves survival in diabetic mice](https://medichelpline.com/clinical-feed/pubmed-42837067.md) (DOI: 10.1007/s10157-026-02956-0)
- [Confounder-adjusted plasma proteomics reveal robust sepsis protein signatures across perioperative](https://medichelpline.com/clinical-feed/medrxiv-16-confounder-adjusted-plasma-proteomics-identify-robust-protein-signatures-in.md)
- [Monocyte phenotypes associated with peri‑coronary inflammation in people with and without HIV](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-distinct-monocyte-phenotypes-are-associated-with-peri-coronary-inflammation-in.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.